# Peter C. Adamson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-c-adamson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,634 |
| Field | Acute Lymphoblastic Leukemia research |
| h-index | 70 |
| i10-index | 203 |
| Last Known Institution | University College London |
| OpenAlex ID | https://openalex.org/A5066484657 |
| ORCID iD | https://orcid.org/0000-0002-9487-757X |
| Works | 322 |

## Researcher papers

- [Understanding and Managing Methotrexate Nephrotoxicity](https://scholariq.org/papers/understanding-and-managing-methotrexate-nephrotoxicity/)
- [Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy](https://scholariq.org/papers/ethosuximide-valproic-acid-and-lamotrigine-in-childhood-absence-epilepsy/)
- [High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma](https://scholariq.org/papers/high-dose-methotrexate-induced-nephrotoxicity-in-patients-with-osteosarcoma/)

## Researcher topics

- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)

## Researcher university

- [University College London](https://scholariq.org/institutions/university-college-london/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.